Form 4: Teradata Corp Executive Hillary Ashton Sells Shares

Sentiment:

SEC Form 4 Filing


Hillary Ashton, Chief Product Officer of Teradata Corp, sold 54,610 shares of common stock on November 7, 2024, at a weighted average price of $29.099 per share.

Summary

  • On November 7, 2024, Hillary Ashton, the Chief Product Officer of Teradata Corp, sold 54,610 shares of the company's common stock.
  • The sale was executed at a weighted average price of $29.099 per share, with individual transaction prices ranging from $28.890 to $29.410.
  • Following the transaction, Ashton directly owns 66,772 shares of Teradata Corp.
  • The reporting person will provide information regarding the number of shares sold at each price within the range upon request.

Sentiment

Score: 5

Explanation: The document itself is neutral, simply reporting a transaction. The sentiment is neutral as it is a standard regulatory filing.

Industry Context

Executive stock sales are a common occurrence and are often scrutinized by investors for insights into management's perspective on the company's valuation and future prospects. However, without additional context, it's difficult to determine the specific reasons behind this sale.

Comparison to Industry Standards

  • Executive stock sales are a normal part of corporate compensation and financial planning.
  • It's common to see executives periodically sell shares to diversify their holdings or for personal financial needs.
  • Comparing this transaction to similar sales by executives at comparable companies (e.g., Snowflake, Databricks, Oracle) would require analyzing their Form 4 filings and considering factors like the size of their holdings, the timing of the sales, and the company's performance.

Stakeholder Impact

  • The sale of shares by a high-ranking executive could potentially create uncertainty among investors, although it is a common practice.
  • The impact on employees, customers, suppliers, and creditors is likely to be minimal unless this sale signals a larger strategic shift within the company.

Key Dates

DateDescription
11/07/2024Date of the stock sale transaction.
11/08/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.